IL129927A0 - 1,4-Diazabicyclo (2.2.2) oct-2-ylmethyl derivatives their preparation and therapeutic application - Google Patents

1,4-Diazabicyclo (2.2.2) oct-2-ylmethyl derivatives their preparation and therapeutic application

Info

Publication number
IL129927A0
IL129927A0 IL12992797A IL12992797A IL129927A0 IL 129927 A0 IL129927 A0 IL 129927A0 IL 12992797 A IL12992797 A IL 12992797A IL 12992797 A IL12992797 A IL 12992797A IL 129927 A0 IL129927 A0 IL 129927A0
Authority
IL
Israel
Prior art keywords
diazabicyclo
oct
preparation
therapeutic application
ylmethyl
Prior art date
Application number
IL12992797A
Other languages
English (en)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL129927A0 publication Critical patent/IL129927A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL12992797A 1996-12-04 1997-12-02 1,4-Diazabicyclo (2.2.2) oct-2-ylmethyl derivatives their preparation and therapeutic application IL129927A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614847A FR2756563B1 (fr) 1996-12-04 1996-12-04 Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
PCT/FR1997/002174 WO1998024790A1 (fr) 1996-12-04 1997-12-02 Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-ylmethyle, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
IL129927A0 true IL129927A0 (en) 2000-02-29

Family

ID=9498306

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12992797A IL129927A0 (en) 1996-12-04 1997-12-02 1,4-Diazabicyclo (2.2.2) oct-2-ylmethyl derivatives their preparation and therapeutic application

Country Status (19)

Country Link
US (1) US6057321A (fr)
EP (1) EP0942910A1 (fr)
JP (1) JP2001504855A (fr)
KR (1) KR20000069283A (fr)
CN (1) CN1239962A (fr)
AU (1) AU7624598A (fr)
BG (1) BG103432A (fr)
BR (1) BR9714215A (fr)
CA (1) CA2271072A1 (fr)
CZ (1) CZ193799A3 (fr)
EE (1) EE9900218A (fr)
FR (1) FR2756563B1 (fr)
HU (1) HUP9904206A3 (fr)
IL (1) IL129927A0 (fr)
NO (1) NO992676L (fr)
NZ (1) NZ336044A (fr)
SK (1) SK74199A3 (fr)
TR (1) TR199901068T2 (fr)
WO (1) WO1998024790A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2223588C (fr) 1995-06-07 2004-01-06 Noven Pharmaceuticals, Inc. Compositions transdermiques contenant des medicaments de faible poids moleculaire liquides a temperature ambiante
WO2004090030A1 (fr) * 2003-04-08 2004-10-21 Ciba Specialty Chemicals Holding Inc. Dispersants polymeres photostabilisants dans des dispersions de pigments
US7880683B2 (en) * 2004-08-18 2011-02-01 Ruckus Wireless, Inc. Antennas with polarization diversity
US8198386B2 (en) 2007-04-16 2012-06-12 Daikin Industries, Ltd. Fluorine-containing elastomer composition and sealing material made of same
CN101842375A (zh) * 2007-09-03 2010-09-22 巴斯夫欧洲公司 制备teda衍生物的方法
CN102046629A (zh) * 2008-05-30 2011-05-04 东曹株式会社 羟基烷基三亚乙基二胺类化合物的制造方法以及使用该化合物的用于制造聚氨酯树脂的催化剂组合物
US20110077376A1 (en) * 2008-05-30 2011-03-31 Katsumi Tokumoto Process for producing hydroxyalkyltriethylenediamine, and catalyst composition for the production of polyurethane resin using it
CN101671336B (zh) * 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途
JP5504835B2 (ja) * 2009-11-13 2014-05-28 東ソー株式会社 ヒドロキシアルキルピペラジン類及び／又はヒドロキシメチルトリエチレンジアミン類の製造方法
JP5549847B2 (ja) * 2009-11-16 2014-07-16 東ソー株式会社 Ｎ−（２−アルコキシメチル）トリエチレンジアミン類の製造法
JP5707912B2 (ja) * 2010-12-08 2015-04-30 東ソー株式会社 Ｎ−（ジヒドロキシアルキル）ジエチレントリアミン類の組成物、及びそれを用いた２−ヒドロキシ（アルキル）トリエチレンジアミン類の製造方
JP6393959B2 (ja) 2012-05-31 2018-09-26 東ソー株式会社 ポリウレタン樹脂製造用触媒組成物及びそれを用いたポリウレタン樹脂の製造方法
JP6252152B2 (ja) * 2013-12-11 2017-12-27 東ソー株式会社 二環式アミン化合物の製造方法
KR20220055152A (ko) 2020-10-26 2022-05-03 인하대학교 산학협력단 급성 융모양막염 진단용 조성물 및 이를 이용한 급성 융모양막염 진단방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
TW282460B (fr) * 1993-12-28 1996-08-01 Yamanouchi Pharma Co Ltd
FR2735475B1 (fr) * 1995-06-13 1997-07-11 Synthelabo Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CZ193799A3 (cs) 1999-09-15
FR2756563A1 (fr) 1998-06-05
NO992676L (no) 1999-07-29
SK74199A3 (en) 2000-02-14
EP0942910A1 (fr) 1999-09-22
TR199901068T2 (xx) 1999-07-21
HUP9904206A2 (hu) 2000-06-28
EE9900218A (et) 1999-12-15
HUP9904206A3 (en) 2000-07-28
CN1239962A (zh) 1999-12-29
KR20000069283A (ko) 2000-11-25
US6057321A (en) 2000-05-02
NO992676D0 (no) 1999-06-02
BG103432A (en) 2000-06-30
CA2271072A1 (fr) 1998-06-11
JP2001504855A (ja) 2001-04-10
BR9714215A (pt) 2000-04-18
NZ336044A (en) 2000-03-27
AU7624598A (en) 1998-06-29
WO1998024790A1 (fr) 1998-06-11
FR2756563B1 (fr) 1998-12-24

Similar Documents

Publication Publication Date Title
AU1393000A (en) 1,4-diazabicyclo(3.2.2)nonane derivatives, their preparation and therapeutic application
HUP9903691A3 (en) Pesticidal karbanilide derivatives, preparation and use thereof
NZ329176A (en) 2,5-dioxo-imidazolidine derivatives and medicaments
NZ314419A (en) Substituted 2,4-aryl-3-hydroxyalkyl pyridines; preparation and medicaments
ZA9711029B (en) Therapeutic agents.
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
SI1019358T2 (sl) 3,3-diarilpropilamini, njihova uporaba in priprava
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
AU4071295A (en) 3-phenylisoquinol-1(2H)-one derivatives, their preparation and their therapeutic application
IL129927A0 (en) 1,4-Diazabicyclo (2.2.2) oct-2-ylmethyl derivatives their preparation and therapeutic application
ZA989664B (en) 3-substituted tetrahydropyrimidinone derivatives, their preparation and use.
HUP0004637A3 (en) Ketone peroxide derivatives, their preparation and use
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
ZA963620B (en) (Het)aryloxy-, -thio- and -aminocrotonates, their preparation and their use.
ZA976619B (en) Benzimidazole derivatives, their preparation and their therapeutic applications.
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
GR3035493T3 (en) Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
HUP9903649A3 (en) Taxane derivatives, the preparation thereof and medical formulations containing them
ZA989571B (en) 2-Substituted 1,2-Benzoisonthiazole derivatives, their preparation and use.
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
ZA978196B (en) Tricyclic indazole derivates, their preparation and their therapeutic application.
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
ZA975771B (en) 1-oxo-1,2-dihydroisoquinoline-4-propanamide derivatives, their preparation and their therapeutic application.
AU1566599A (en) 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoline-4-propanamide derivatives, preparation and therapeutic application
IL133242A0 (en) 5-Naphthalene-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application